Iloprost for the attenuation of ischaemia/reperfusion injury in a distant organ

Cell Biochemistry and Function

Volumn 24, Issue 4, 2006, Pages 341-346

  Aytacoglu, Barlas N ^a,b   Sucu, Nehir ^a   Tamer, Lulufer ^a   Polat, Ayse ^a   Gul, Ali ^a   Degirmenci, Ulas ^a   Mavioglu, Ilhan ^a   Dikmengil, Murat ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Iloprost; Ischaemia reperfusion injury; Kidney

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ILOPROST; MALONALDEHYDE; MYELOPEROXIDASE; THIOPENTAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CELL PROTECTION; CONTROLLED STUDY; HINDLIMB; HISTOPATHOLOGY; ISCHEMIA; KIDNEY PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; HINDLIMB; ILOPROST; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; PEROXIDASE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY;

RATTUS NORVEGICUS;

EID: 33745973654     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1223     Document Type: Article

References (25)

1. Campbell WB, Collins J, Morris PJ. The mortality of abdominal aortic aneurysm. Ann R Col Surg Engl 1986; 68: 275-278.
2. Soreide O, Grimsgaard CHR, Solheim K, Trippestad A. Time and cause of death for 301 patients operated on for abdominal aortic aneurysm. Age Ageing 1982; 11: 256-260.
3. Paterson IS, Klausner JM, Pugatch R, et al. Noncardiogenic pulmonary oedema after abdominal aortic aneurysm surgery. Ann Surg 1989; 209: 31-236.
4. Rowlands TE, Gough MJ, Homer-Vanniasinkam S. Do prostaglandins have a salutary role in skeletal muscle ischemia-reperfusion injury? Eur J Vasc Endovasc Surg 1999; 18: 439-444.
5. Sucu N, Unlu A, Tamer L, et al. Effects of trimetazidine on tissue damage in kidney after hind limb ischemia-reperfusion. Pharmacol Res 2002; 46: 345-349.
6. Carden DL, Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol 2000; 190: 255-266.
7. 2 integrin. Eur J Clin Invest 1996; 26: 860-866.
8. Grant SM, Goa KL. Iloprost: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992; 43: 889-924.
9. Krause W, Krais Th. Pharmacokinetics and pharmacodynamics of radio-labelled iloprost in elderly volunteers. Eur J Clin Pharmacol 1987; 32: 597-605.
10. Golowich SP, Kaplan SD. Methods in Enzymology, vol. 2. Academic Press Inc.: New York, 1955; 769.
11. Yagi K. Lipid peroxides and related radicals in clinical medicine. In Free Radicals in Diagnostic Medicine, Armstrong D (ed.). Plenum Press: New York, 1994; 1-15.
12. Bishop ML, Janet LP. Free Radicals in Clinical Chemistry (3rd edn). JB Lippincott: New York and Philadelphia, 1996; 765-777.
13. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-412.
14. Reading HW, Isbir T. Action of lithium on ATPase in transmitter release from rat Iris. Biochem Pharmacol 1979; 28: 3471-3474.
15. Reading HW, Isbir T. The role of cation-activated ATPases in transmitter release from the rat iris. Quart J Exp Physiol 1988; 65: 105-116.
16. Lowry OH, Rosebrough NJ, Farr AI, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1954; 193: 265-275.
17. Özer Z, Sucu N, Düşmez D, et al. The effect of aprotinin on ischemia-reperfusion injury in the rabbit kidney. Pharmacol Res 2001; 44: 455-460.
18. Bozkurt AK. α-Tocopherol (vitamin E) and iloprost attenuate reperfusion injury in skeletal muscle ischemia/reperfusion injury. J Cardiovasc Surg 2002; 43: 693-696.
19. Gutteridge J. Free radicals in disease processes: a compilation of cause and consequence. Free Radic Res 1993; 19: 141-148.
20. + ATPase related lipid peroxidation in ischemic and reperfused rabbit kidney. Gen Pharmac 1994; 25: 341-344.
21. Farber EN, Pieper GM, Thomas JP, Gross GJ. Beneficial effects of iloprost in the stunned canine myocardium. Circulation Research 1988; 62: 204-215.
22. Dosluoǧlu UH, Aktan AO, Yegen C, et al. The cytoprotective effects of verapamil and iloprost (ZK 36374) on ischemia/reperfusion injury of kidneys. Transpl Int 1993; 6: 138-142.
23. Kawashima M, Nakamura T, Schneider S, et al. Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance. J Heart Lung Transplant 2003; 22: 794-801.
24. Takeuchi K, Suzuki S, Kako N, et al. A prostacyclin analogue reduces free radical generation in heart-lung transplantation. Ann Thorac Surg 1992; 54: 327-332.
25. Duthois S, Cailleux N, Benosman B, Lévesque H. Tolerance of iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases. Diabetes Metab 2003; 29: 36-43.